» Articles » PMID: 7682182

Morphological Changes in the Rat Neostriatum After Unilateral 6-hydroxydopamine Injections into the Nigrostriatal Pathway

Overview
Journal Exp Brain Res
Specialty Neurology
Date 1993 Jan 1
PMID 7682182
Citations 44
Authors
Affiliations
Soon will be listed here.
Abstract

Destruction of the dopamine-containing neurons in the rat substantia nigra results in morphological changes in the striatum which have been characterized at both the light and electron microscopic levels. After a unilateral 6-hydroxydopamine injection into the medial forebrain bundle, Golgi-impregnated medium-sized spiny neurons in the neostriatum ipsilateral to the injection had a lower density of spines on their dendrites than those on the contralateral side. A similar decrease in spine density was apparent from 12 days until at least 13.5 months after the lesion. A bilateral loss of spines occurred with increasing age regardless of the presence or absence of the nigrostriatal dopaminergic pathway. At the ultrastructural level, the general pattern of synaptic input to the Golgi-impregnated medium-sized spiny neurons was similar on both sides of the brain. The most obvious class of afferent boutons contacting these spiny neurons formed prominent asymmetrical synaptic specializations with the heads of the spines. The numbers of asymmetric synaptic profiles counted in random electron micrographs from the striata ipsilateral and contralateral to the lesion were not significantly different from each other. A small but significant increase in the length of asymmetric synaptic specialization profiles was, however, detected in the striata lacking a dopamine input.

Citing Articles

The effect of growth hormone on motor findings and dendrite morphology in an experimental Parkinson's disease model.

Kirazli O, Ozkan M, Verimli U, Gulhan R, Arman A, Sehirli U Anat Sci Int. 2024; 100(1):79-87.

PMID: 39085683 DOI: 10.1007/s12565-024-00790-6.


Transfection of the BDNF Gene in the Surviving Dopamine Neurons in Conjunction with Continuous Administration of Pramipexole Restores Normal Motor Behavior in a Bilateral Rat Model of Parkinson's Disease.

Benitez-Castaneda A, Anaya-Martinez V, Espadas-Alvarez A, Gutierrez-Valdez A, Razgado-Hernandez L, Reyna-Velazquez P Parkinsons Dis. 2024; 2024:3885451.

PMID: 38419644 PMC: 10901579. DOI: 10.1155/2024/3885451.


Spike-Timing-Dependent Plasticity Mediated by Dopamine and its Role in Parkinson's Disease Pathophysiology.

Madadi Asl M, Vahabie A, Valizadeh A, Tass P Front Netw Physiol. 2023; 2:817524.

PMID: 36926058 PMC: 10013044. DOI: 10.3389/fnetp.2022.817524.


The Role of Striatal Cav1.3 Calcium Channels in Therapeutics for Parkinson's Disease.

Caulfield M, Manfredsson F, Steece-Collier K Handb Exp Pharmacol. 2023; 279:107-137.

PMID: 36592226 DOI: 10.1007/164_2022_629.


HIV-Associated Apathy/Depression and Neurocognitive Impairments Reflect Persistent Dopamine Deficits.

McLaurin K, Harris M, Madormo V, Harrod S, Mactutus C, Booze R Cells. 2021; 10(8).

PMID: 34440928 PMC: 8392364. DOI: 10.3390/cells10082158.


References
1.
Sivam S, Breese G, Krause J, Napier T, Mueller R, Hong J . Neonatal and adult 6-hydroxydopamine-induced lesions differentially alter tachykinin and enkephalin gene expression. J Neurochem. 1987; 49(5):1623-33. DOI: 10.1111/j.1471-4159.1987.tb01036.x. View

2.
Chang H, Wilson C, Kitai S . A Golgi study of rat neostriatal neurons: light microscopic analysis. J Comp Neurol. 1982; 208(2):107-26. DOI: 10.1002/cne.902080202. View

3.
Whishaw I, OConnor W, Dunnett S . The contributions of motor cortex, nigrostriatal dopamine and caudate-putamen to skilled forelimb use in the rat. Brain. 1986; 109 ( Pt 5):805-43. DOI: 10.1093/brain/109.5.805. View

4.
Segovia J, Garcia-Munoz M . Changes in the activity of GAD in the basal ganglia of the rat after striatal dopaminergic denervation. Neuropharmacology. 1987; 26(9):1449-51. DOI: 10.1016/0028-3908(87)90113-4. View

5.
Bouyer J, Park D, Joh T, Pickel V . Chemical and structural analysis of the relation between cortical inputs and tyrosine hydroxylase-containing terminals in rat neostriatum. Brain Res. 1984; 302(2):267-75. DOI: 10.1016/0006-8993(84)90239-7. View